JP2024520912A5 - - Google Patents

Info

Publication number
JP2024520912A5
JP2024520912A5 JP2023569859A JP2023569859A JP2024520912A5 JP 2024520912 A5 JP2024520912 A5 JP 2024520912A5 JP 2023569859 A JP2023569859 A JP 2023569859A JP 2023569859 A JP2023569859 A JP 2023569859A JP 2024520912 A5 JP2024520912 A5 JP 2024520912A5
Authority
JP
Japan
Prior art keywords
composition according
approximately
tacrolimus
dose
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023569859A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520912A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/028972 external-priority patent/WO2022241105A1/en
Publication of JP2024520912A publication Critical patent/JP2024520912A/ja
Publication of JP2024520912A5 publication Critical patent/JP2024520912A5/ja
Pending legal-status Critical Current

Links

JP2023569859A 2021-05-12 2022-05-12 1日1回(qd)の吸入による投与のためのタクロリムスの乾燥粉末製剤 Pending JP2024520912A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163187774P 2021-05-12 2021-05-12
US63/187,774 2021-05-12
PCT/US2022/028972 WO2022241105A1 (en) 2021-05-12 2022-05-12 Dry powder formulations of tacrolimus for administration by inhalation once daily (qd)

Publications (2)

Publication Number Publication Date
JP2024520912A JP2024520912A (ja) 2024-05-27
JP2024520912A5 true JP2024520912A5 (https=) 2025-05-16

Family

ID=81928015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023569859A Pending JP2024520912A (ja) 2021-05-12 2022-05-12 1日1回(qd)の吸入による投与のためのタクロリムスの乾燥粉末製剤

Country Status (7)

Country Link
US (1) US20220362222A1 (https=)
EP (1) EP4337173A1 (https=)
JP (1) JP2024520912A (https=)
CN (1) CN117750945A (https=)
AU (1) AU2022271790A1 (https=)
CA (1) CA3219943A1 (https=)
WO (1) WO2022241105A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118948810A (zh) * 2024-07-26 2024-11-15 四川大学 一种吸入式的mPEG-PLGA/FK506载药纳米颗粒及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2691531C (en) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
AU2009214443B2 (en) 2008-02-13 2013-10-10 Board Of Regents, The University Of Texas System Templated open flocs of anisotropic particles for enhanced pulmonary delivery
WO2011163600A2 (en) * 2010-06-25 2011-12-29 Apt Pharmaceuticals, Inc. Tacrolimus compositions for aerosol administration

Similar Documents

Publication Publication Date Title
US8962601B2 (en) Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
JP4612956B2 (ja) 抗コリン作用化合物及びβ−擬似剤に基づく新規医薬組成物
US6616914B2 (en) Method for pulmonary and oral delivery of pharmaceuticals
HRP20110129T1 (hr) Sastavi koji sadrže kristalni trans-(+/-)-delta-9-tetrahidrokanabinol
JP2022137070A5 (https=)
JPH08504438A (ja) 医薬活性化合物を投与するための系
RU2013119938A (ru) Фармацевтическая композиция
US20050042174A1 (en) Combined doses
UA119774C2 (uk) Комбінації формотеролу і будесоніду для лікування хронічної обструктивної хвороби легень (хохл)
JP2005508963A (ja) 喘息を治療するためのサルメテロールとフルチカゾンプロピオネートを含む医薬の組み合せ
ZA200301475B (en) Pharmaceutical formulation of salmeterol and fluticasone propionate.
JP2024520912A5 (https=)
JP2023523557A5 (https=)
US20050053553A1 (en) Combined doses of formoterol and fluticasone
WO2004110404A1 (en) Combined doses of tiotropium and fluticasone
WO2025167739A1 (zh) 化合物在制备预防和/或治疗高原病的药物中的应用
Morris et al. The efficacy of drug delivery by a pear-shaped spacer and metered dose inhaler
US20080107740A1 (en) Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders
CN114344380A (zh) 一种止喘灵雾化吸入用溶液制剂及其制备方法
US20050042175A1 (en) Combined doses of formoterol and budesonide
US12414956B2 (en) Method for smoking cessation
JPS6034910A (ja) 経口いびき止め剤
Kravis et al. Therapeutic aerosols in childhood asthma: a review with clinical observations on two new preparations
JPS6360926A (ja) 感冒薬
CN103006657B (zh) 一种含有愈创木酚的复方化学药物